Article Draft edit

 
Human pancreatic islet by immunostaining. Nuclei of cells are shown in blue (DAPI). Beta cells are shown in green (Insulin), Delta cells are shown in white (Somatostatin).

Beta cells (β-cells), are specialized endocrine cells located within the pancreatic islets responsible for the production and release of insulin and amylin.[1] Constituting ~50–70% of cells in human islets, beta cells play a vital role in maintaining blood glucose levels. [2]Problems with beta cells can lead to disorders such as diabetes.[3]

Function[edit] edit

The function of beta cells is primarily centered around the synthesis and secretion of hormones, particularly insulin and amylin. Both hormones work to keep blood glucose levels within a narrow, healthy range by different mechanisms.[4] Insulin facilitates the uptake of glucose by cells, allowing them to use it for energy or store it for future use[5] Amylin helps regulate the rate at which glucose enters the bloodstream after a meal, slowing down the absorption of nutrients by inhibit gastric emptying[6].

Insulin synthesis edit

Insulin secretion edit

Other hormones secreted edit

Clinical significance[edit] edit

Beta cells have significant clinical relevance as their proper function is essential for glucose regulation, and dysfunction is a key factor in the development and progression of diabetes and its associated complications[7]. Here are some key clinical significances of beta cells:

Type 1 diabetes edit

Type 2 diabetes edit

Insulinoma edit

References edit

  1. ^ Dolenšek, Jurij; Rupnik, Marjan Slak; Stožer, Andraž (2015-01-02). "Structural similarities and differences between the human and the mouse pancreas". Islets. 7 (1): e1024405. doi:10.1080/19382014.2015.1024405. ISSN 1938-2014.
  2. ^ Chen, Chunguang; Cohrs, Christian M.; Stertmann, Julia; Bozsak, Robert; Speier, Stephan (2017-09). "Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis". Molecular Metabolism. 6 (9): 943–957. doi:10.1016/j.molmet.2017.06.019. {{cite journal}}: Check date values in: |date= (help)
  3. ^ Ashcroft, Frances M; Rorsman, Patrik (2012-03-16). "Diabetes mellitus and the β-cell: the Last Ten Years". Cell. 148 (6): 1160–1171. doi:10.1016/j.cell.2012.02.010. ISSN 0092-8674. PMC 5890906. PMID 22424227.
  4. ^ Boland, Brandon B.; Rhodes, Christopher J.; Grimsby, Joseph S. (2017-09). "The dynamic plasticity of insulin production in β-cells". Molecular Metabolism. 6 (9): 958–973. doi:10.1016/j.molmet.2017.04.010. {{cite journal}}: Check date values in: |date= (help)
  5. ^ Wilcox, Gisela (2005-5). "Insulin and Insulin Resistance". Clinical Biochemist Reviews. 26 (2): 19–39. ISSN 0159-8090. PMC 1204764. PMID 16278749. {{cite journal}}: Check date values in: |date= (help)
  6. ^ Westermark, Per; Andersson, Arne; Westermark, Gunilla T. (2011-07). "Islet amyloid polypeptide, islet amyloid, and diabetes mellitus". Physiological Reviews. 91 (3): 795–826. doi:10.1152/physrev.00042.2009. ISSN 1522-1210. PMID 21742788. {{cite journal}}: Check date values in: |date= (help)
  7. ^ Sakran, Nasser; Graham, Yitka; Pintar, Tadeja; Yang, Wah; Kassir, Radwan; Willigendael, Edith M.; Singhal, Rishi; Kooreman, Zoë E.; Ramnarain, Dharmanand; Mahawar, Kamal; Parmar, Chetan; Madhok, Brijesh; Pouwels, Sjaak (2022-01-07). "The many faces of diabetes. Is there a need for re-classification? A narrative review". BMC Endocrine Disorders. 22 (1): 9. doi:10.1186/s12902-021-00927-y. ISSN 1472-6823. PMC 8740476. PMID 34991585.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)